A phosphorylcholine-modified chitosan polymer as an endothelial progenitor cell supporting matrix

Biomaterials

Volumn 32, Issue 22, 2011, Pages 5046-5055

  Tardif, Kim ^a   Cloutier, Isabelle ^a   Miao, Zhimei ^b   Lemieux, Caroline ^a   St Denis, Corinne ^a   Winnik, Françoise M ^b   Tanguay, Jean François ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Biocompatibility; Biopolymer; Chitosan Phosphorylcholine; EPC

Indexed keywords

ADHESION MECHANISMS; CELL RETENTION; CHITOSAN-PHOSPHORYLCHOLINE; CONTROL MATRICES; ENDOTHELIAL PROGENITOR CELLS; EPC; FLOW CYTOMETRY ANALYSIS; MATRIX; MESENCHYMAL STEM CELL; MORTALITY RATE; POLYMERIC SUBSTRATE; PROGENITOR CELL; THERAPEUTIC APPLICATION; VEGFR-2;

AMPLIFICATION; BIOCOMPATIBILITY; BIOMOLECULES; CHITOSAN; CONFOCAL MICROSCOPY; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FUNCTIONAL POLYMERS; HEART VALVE PROSTHESES; MULTILAYERS; STEM CELLS;

CELL CULTURE;

CD31 ANTIGEN; CD34 ANTIGEN; CHITOSAN; FIBRONECTIN; HERMES ANTIGEN; PHOSPHORYLCHOLINE; POLYMER; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE MARROW CELL; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; MESENCHYMAL STEM CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHITOSAN; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; PHOSPHORYLCHOLINE; POLYMERS; RATS; STEM CELLS;

EID: 79956124893     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.002     Document Type: Article

References (43)

1. Babin-Ebell J., Sievers H.H., Charitos E.I., Klein H.M., Jung F., Hellberg A.K., et al. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort. Thorac Cardiovasc Surg 2010, 58(1):11-16.
2. Mollmann H., Nef H., Elsasser A., Hamm C. Stem cells in myocardial infarction: from bench to bedside. Heart 2009, 95(6):508-514.
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
4. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92(2):362-367.
5. Werner N., Priller J., Laufs U., Endres M., Bohm M., Dirnagl U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22(10):1567-1572.
6. Leone A.M., Rutella S., Bonanno G., Abbate A., Rebuzzi A.G., Giovannini S., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005, 26(12):1196-1204.
7. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-E7.
8. Klim J.R., Li L., Wrighton P.J., Piekarczyk M.S., Kiessling L.L. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods 2010, 7(12):989-994.
9. Brafman D.A., Chang C.W., Fernandez A., Willert K., Varghese S., Chien S. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 2010, 31(34):9135-9144.
10. Kumar M.N., Muzzarelli R.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004, 104(12):6017-6084.
11. Tiera M.J., Qiu X.P., Bechaouch S., Shi Q., Fernandes J.C., Winnik F.M. Synthesis and characterization of phosphorylcholine-substituted chitosans soluble in physiological pH conditions. Biomacromolecules 2006, 7(11):3151-3156.
12. Sawada S., Sakaki S., Iwasaki Y., Nakabayashi N., Ishihara K. Suppression of the inflammatory response from adherent cells on phospholipid polymers. J Biomed Mater Res A 2003, 64(3):411-416.
13. Lemieux C., Cloutier I., Tanguay J.F. Estrogen-induced gene expression in bone marrow c-kit+ stem cells and stromal cells: identification of specific biological processes involved in the functional organization of the stem cell niche. Stem Cells Dev 2008, 17(6):1153-1163.
14. Moioli E.K., Clark P.A., Chen M., Dennis J.E., Erickson H.P., Gerson S.L., et al. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS ONE 2008, 3(12):e3922.
15. Miyazawa K.W., Winnik F.M. Solution properties of phosphorylcholine-based hydrophobically modified polybetaines in water and mixed solvents. Macromolecules 2002, 35(25):9536-9544.
16. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006, 8(4):315-317.
17. Babapulle M.N., Eisenberg M.J. Coated stents for the prevention of restenosis: part I. Circulation 2002, 106(21):2734-2740.
18. Lauto A., Ohebshalom M., Esposito M., Mingin J., Li P.S., Felsen D., et al. Self-expandable chitosan stent: design and preparation. Biomaterials 2001, 22(13):1869-1874.
19. Whelan D.M., van der Giessen W.J., Krabbendam S.C., van Vliet E.A., Verdouw P.D., Serruys P.W., et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000, 83(3):338-345.
20. Ratner BD, Hoffman, A.S., Schoen, F.J., Lemons, J.E. Biomaterials science: an introduction to materials in medicine. 2nd ed. Press EA, editor. San Diego 2004.
21. Prowse A.B., Chong F., Gray P.P., Munro T.P. Stem cell integrins: Implications for ex-vivo culture and cellular therapies. Stem Cell Res 2011, 6(1):1-12.
22. Pierschbacher M., Hayman E.G., Ruoslahti E. Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A 1983, 80(5):1224-1227.
23. Lauffenburger D.A., Griffith L.G. Who's got pull around here? Cell organization in development and tissue engineering. Proc Natl Acad Sci U S A 2001, 98(8):4282-4284.
24. Rose S.F., Lewis A.L., Hanlon G.W., Lloyd A.W. Biological responses to cationically charged phosphorylcholine-based materials in vitro. Biomaterials 2004, 25(21):5125-5135.
25. Reisch A., Voegel J.C., Gonthier E., Decher G., Senger B., Schaaf P., et al. Polyelectrolyte multilayers capped with polyelectrolytes bearing phosphorylcholine and triethylene glycol groups: parameters influencing antifouling properties. Langmuir 2009, 25(6):3610-3617.
26. Ladam G.S.P., Decher G., Voegel J., Cuisinier F.J. Protein adsorption onto auto-assembled polyelectrolyte films. Langmuir 2001, 19(6).
27. Barbucci R., Magnani A. Conformation of human plasma proteins at polymer surfaces: the effectiveness of surface heparinization. Biomaterials 1994, 15(12):955-962.
28. Zheng J., Ito Y., Imanishi Y. Cell growth on immobilized cell-growth factor. 10. Insulin and polyallylamine co-immobilized materials. Biomaterials 1994, 15(12):963-968.
29. Huang Y., Siewe M., Madihally S.V. Effect of spatial architecture on cellular colonization. Biotechnol Bioeng 2006, 93(1):64-75.
30. Cai X., Lin Y., Friedrich C.C., Neville C., Pomerantseva I., Sundback C.A., et al. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev 2009, 5(4):437-445.
31. Nehls V., Denzer K., Drenckhahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 1992, 270(3):469-474.
32. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9(6):702-712.
33. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004, 287(3):C572-C579.
34. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001, 7(9):1035-1040.
35. Zampetaki A., Kirton J.P., Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008, 78(3):413-421.
36. Zhu H., Mitsuhashi N., Klein A., Barsky L.W., Weinberg K., Barr M.L., et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006, 24(4):928-935.
37. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28(3):585-596.
38. Petrie T.A., Raynor J.E., Dumbauld D.W., Lee T.T., Jagtap S., Templeman K.L., et al. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci Transl Med 2010, 2(45). 45ra60.
39. Thomas T.E., Miller C.L., Eaves C.J. Purification of hematopoietic stem cells for further biological study. Methods 1999, 17(3):202-218.
40. Mayani H. A glance into somatic stem cell biology: basic principles, new concepts, and clinical relevance. Arch Med Res 2003, 34(1):3-15.
41. Szilvassy S.J., Hoffman R. Enriched hematopoietic stem cells: basic biology and clinical utility. Biol Blood Marrow Transplant 1995, 1(1):3-17.
42. Watt F.M., Hogan B.L. Out of eden: stem cells and their niches. Science 2000, 287(5457):1427-1430.
43. Huhtala M.T., Pentikainen O.T., Johnson M.S. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding. Structure 1999, 7(6):699-709.